Zoom | March 7-9th 2023 | 09:30 - 11:30 | English
Sino-UK Healthcare Summit 2023
Join our complimentary three-day webinar for an intensive and insightful look into the opportunities, risks, and challenges of China’s burgeoning healthcare market.
EVENT: Sino-UK Healthcare Summit
DATE: March 7-9th, 2023
TIME: 09:30-11:30 GMT
Driven by a rapidly aging population, increasing income levels, and rising chronic disease rates the Chinese healthcare market has become one of the largest and fastest-growing in the world which has created significant opportunities for UK healthcare innovators.
Serica, the UK Department for Business & Trade, and Santander are delighted to invite you to our virtual Sino-UK Healthcare Summit. This event is ideal for ambitious, UK-based healthcare scaleups, particularly those in life sciences, medtech, and digital health. We’ll help you discover potential new revenue streams and innovation-development opportunities, dispelling your lack of market knowledge so you can make decisions and plan with confidence.
Our complimentary three-day webinar will provide a 360° overview of the market, with each day focusing on a different aspect of doing business in China.
Day 1 – Innovations & Opportunities
Showcase the cutting-edge innovations in China and the opportunities available for you to seize. Beginning with opening remarks from John Edwards (HM Trade Commissioner for China, the UK Department for Business and Trade), a keynote from Benjamin Speyer (CEO at Serica) will provide a broad overview of the market, followed by keynotes from Chandler Chen (Executive Director, iCampus, Astra Zeneca), Sheng Ge (Director of Strategy Development, Wei Mai), Yiran Song (Managing Director, Marathon Venture Partners), and other leading healthcare companies (more to be announced soon) to showcase their China-based innovations and market insights. The day will conclude with a panel moderated by Kiran Patel (Senior Director, CBBC) featuring several UK healthcare innovators who will share their experiences and successes of doing business in China.
Day 2 – Challenges & Risks
Uncover and demystify the risks and challenges you will encounter such as regulatory approval, product localization, and IP protection. Gary Hunt (Director of Life Sciences & Healthcare, UK Department for Business and Trade) will provide an introductory keynote on China’s regulatory environment. Following on, a series of experts will share insight on their company’s specialties; Sarunas Nastys (COO, Serica) will discuss assessing your China readiness; Alex Roberts (Partner, Linklaters) provides insight on managing intellectual property in China; Leo Shen (Head of Technology, Hays China) shares his thoughts on recruiting and retaining local talent; Rosie Hawes (Partner, Control Risks) discusses conducting effective due diligence to mitigate risks; and Angie Zhu (General Manager, Microsoft AI & IoT Lab-Shanghai) will discuss how to localize your solutions for the Chinese market; Ray Chisnall (Chair, BritCham Shanghai) will share information about, and how you can integrate into, the British community in East China.
Day 3 – Market Entry 101
Compare the different modes of entry you can take into the market and hear directly from prospective buyers, investors, and partners. Duke Wang (Managing Partner & Head of China, Serica) will share insights on organic and inorganic entry strategies; Richard Barham (Corporate Partner, Dentons) will discuss legal considerations prior to entry; Alex Phillips (China Corridor Director, Santander) and Elaine Feng (Product Manager, Bank of Shanghai) will cover the key financial considerations you will need to make and how Santander can support you in the market; Hamish King (COO, Cisema) and Victoria Caldy (BD & Marketing Director, Cisema) will talk through how to get regulatory approval efficiently. The day will conclude with a panel featuring prospective investors and partners including Henry Huang, (CEO, Hakim Unique Group), Oscar Ramos (GM & MD of SOSV), and Archie Preston (Overseas Strategy & Investment Director) who will share what they look for when investing or doing business with healthcare innovators.